scholarly article | Q13442814 |
P50 | author | Hans Hauner | Q21033707 |
Hannelore Daniel | Q1575859 | ||
P2093 | author name string | Thomas Skurk | |
Tamara Zietek | |||
Ramona Pais | |||
P2860 | cites work | Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4). | Q46818578 |
Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in non-obese diabetic mice. | Q47214393 | ||
Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES | Q24304260 | ||
The novel chemokine receptor, G-protein-coupled receptor 75, is expressed by islets and is coupled to stimulation of insulin secretion and improved glucose homeostasis | Q24319758 | ||
Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1 | Q24682766 | ||
G-protein-coupled receptors in intestinal chemosensation | Q26828554 | ||
The role of SGLT1 and GLUT2 in intestinal glucose transport and sensing | Q27319522 | ||
Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils | Q28205971 | ||
Rapid insertion of GLUT2 into the rat jejunal brush-border membrane promoted by glucagon-like peptide 2 | Q28577695 | ||
Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2 | Q28592795 | ||
Role of leptin in the regulation of glucagon-like peptide-1 secretion | Q28609244 | ||
The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat. | Q31725223 | ||
Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides | Q33788748 | ||
Proglucagon gene expression is regulated by a cyclic AMP-dependent pathway in rat intestine | Q33865081 | ||
Development of glucagon-like peptide-1-based pharmaceuticals as therapeutic agents for the treatment of diabetes | Q34319292 | ||
The biology of incretin hormones | Q34499706 | ||
Sugar absorption in the intestine: the role of GLUT2. | Q34656042 | ||
Terminal arteriolar network structure/function and plasma cytokine levels in db/db and ob/ob mouse skeletal muscle | Q34842420 | ||
Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. | Q34857481 | ||
Oligopeptides stimulate glucagon-like peptide-1 secretion in mice through proton-coupled uptake and the calcium-sensing receptor | Q34991604 | ||
Enhancing Incretin Action for the Treatment of Type 2 Diabetes | Q35545683 | ||
Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion | Q35612377 | ||
Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1 alpha, or human interleukin 8 | Q36362602 | ||
Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: preclinical biology and mechanisms of action | Q36751470 | ||
Induction of intestinal epithelial proliferation by glucagon-like peptide 2. | Q37449481 | ||
Glutamine triggers and potentiates glucagon-like peptide-1 secretion by raising cytosolic Ca2+ and cAMP. | Q39796503 | ||
CCL5 promotes macrophage recruitment and survival in human adipose tissue | Q39932026 | ||
Cyclic AMP triggers glucagon-like peptide-1 secretion from the GLUTag enteroendocrine cell line | Q40104293 | ||
Meat hydrolysate and essential amino acid-induced glucagon-like peptide-1 secretion, in the human NCI-H716 enteroendocrine cell line, is regulated by extracellular signal-regulated kinase1/2 and p38 mitogen-activated protein kinases | Q40215541 | ||
Differential chemokine activation of CC chemokine receptor 1-regulated pathways: ligand selective activation of Galpha 14-coupled pathways | Q40584252 | ||
Morbidly obese human subjects have increased peripheral blood CD4+ T cells with skewing toward a Treg- and Th2-dominated phenotype. | Q40666702 | ||
Glucose-sensing in glucagon-like peptide-1-secreting cells | Q40708590 | ||
A human cellular model for studying the regulation of glucagon-like peptide-1 secretion | Q40779469 | ||
Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. | Q41229926 | ||
Comparison of RANTES expression in Crohn's disease and ulcerative colitis: an aid in the differential diagnosis? | Q41909650 | ||
Role of phosphodiesterase and adenylate cyclase isozymes in murine colonic glucagon-like peptide 1 secreting cells | Q42087161 | ||
Expression and secretion of RANTES (CCL5) in human adipocytes in response to immunological stimuli and hypoxia | Q42443891 | ||
Contrasting roles for RANTES and macrophage inflammatory protein-1 alpha (MIP-1 alpha) in a murine model of allergic peritonitis | Q42476082 | ||
Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice | Q43266171 | ||
Relation of circulating concentrations of chemokine receptor CCR5 ligands to C-peptide, proinsulin and HbA1c and disease progression in type 1 diabetes | Q44280561 | ||
P433 | issue | 3 | |
P921 | main subject | insulin secretion involved in cellular response to glucose stimulus | Q21108800 |
P304 | page(s) | G330-7 | |
P577 | publication date | 2014-05-29 | |
P1433 | published in | American Journal of Physiology - Gastrointestinal and Liver Physiology | Q15765756 |
P1476 | title | RANTES (CCL5) reduces glucose-dependent secretion of glucagon-like peptides 1 and 2 and impairs glucose-induced insulin secretion in mice | |
P478 | volume | 307 |
Q26797335 | DPP4 in Diabetes |
Q89442824 | Glucagon-like Peptide-2 and the Regulation of Intestinal Growth and Function |
Q26752511 | Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1 |
Q92799597 | Insights on the Role of Putative Muscle-Derived Factors on Pancreatic Beta Cell Function |
Q26765259 | Stimulation of incretin secreting cells |
Search more.